Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute pulmonary embolism: risk stratification.

Samuel Z Goldhaber1

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. sgoldhaber@partners.org

Pathophysiology of Haemostasis and Thrombosis
|July 21, 2006
PubMed
Summary

Acute pulmonary embolism (PE) has a high death rate. Rapid risk stratification using clinical evaluation, nonimaging tests, imaging, and biomarkers helps identify high-risk patients for timely, aggressive therapy, improving outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superficial Vein Thrombosis: A Review.

JAMA·2025
Same author

Apixaban for Extended Treatment of Provoked Venous Thromboembolism.

The New England journal of medicine·2025
Same author

Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications.

Thrombosis and haemostasis·2025
Same author

Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data.

Seminars in thrombosis and hemostasis·2025
Same author

Aspirin for Venous Thromboembolism Prophylaxis in Hip Fracture, Total Knee, and Hip Arthroplasty.

The American journal of medicine·2025
Same author

Non-O Blood Groups and Cardiovascular Outcomes in COVID-19: Findings From a Large Multicenter Study.

JACC. Advances·2025

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Acute pulmonary embolism (PE) carries a mortality rate exceeding that of acute myocardial infarction.
  • Traditional management involved a
  • watch and wait
  • approach, often leading to irreversible cardiogenic shock and multisystem organ failure.
  • Optimizing patient selection for aggressive therapies like thrombolysis or embolectomy is crucial.

Purpose of the Study:

  • To introduce a new paradigm for managing acute pulmonary embolism (PE) based on rapid and accurate risk stratification.
  • To highlight the components of this new strategy for identifying high-risk PE patients.

Main Methods:

  • The new strategy integrates four key components: clinical evaluation, bedside nonimaging tests (ECG, pulse oximetry), imaging tests (echocardiography, CT), and cardiac biomarkers (troponin).

Related Experiment Videos

  • This multi-faceted approach enables prompt identification of patients requiring urgent or emergent interventions.

    • Main Results:

    • Rapid risk stratification allows for the identification of high-risk patients before overt hypotension and cardiogenic shock develop.
    • This enables timely triage for aggressive therapies, potentially preventing severe complications.

    Conclusions:

    • A shift from passive monitoring to active, risk-stratified management is essential for improving outcomes in acute pulmonary embolism (PE).
    • Early identification and intervention in high-risk PE patients can significantly reduce mortality and morbidity.